MedPath
HSA Approval

Angizaar-50mg Tablet

SIN13720P

Angizaar-50mg Tablet

Angizaar-50mg Tablet

November 2, 2009

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNAINA MOHAMED & SONS PRIVATE LIMITED
Licence HolderNAINA MOHAMED & SONS PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C09CA01

losartan

Manufacturer Information

NAINA MOHAMED & SONS PRIVATE LIMITED

Micro Labs Ltd

Active Ingredients

Losartan potassium

50 mg

Losartan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Angizaar-50mg Tablet - HSA Approval | MedPath